Chimin Health Management Co., Ltd.

Shanghai Stock Exchange 603222.SS

Chimin Health Management Co., Ltd. Gross Profit for the year ending December 31, 2023: USD 53.36 M

Chimin Health Management Co., Ltd. Gross Profit is USD 53.36 M for the year ending December 31, 2023, a -4.98% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Chimin Health Management Co., Ltd. Gross Profit for the year ending December 31, 2022 was USD 56.15 M, a -32.40% change year over year.
Chimin Health Management Co., Ltd. Gross Profit for the year ending December 31, 2021 was USD 83.06 M, a 50.48% change year over year.
Chimin Health Management Co., Ltd. Gross Profit for the year ending December 31, 2020 was USD 55.20 M, a 9.39% change year over year.
Chimin Health Management Co., Ltd. Gross Profit for the year ending December 31, 2019 was USD 50.46 M, a 19.77% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

Shanghai Stock Exchange: 603222.SS

Chimin Health Management Co., Ltd.

CEO	Mr. Yunfei Tian
IPO Date	Feb. 17, 2015
Location	China
Headquarters	No. 888, Beiyuan Road
Employees	1,947
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.

Key trends

Past 5 years